Position in ABBV
as of Mar 31, 2026
· filed Apr 7, 2026
Position Value
$11,452,153
+$174,116 QoQ
Shares Held
52,656
+6.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026U.S. Capital Wealth Advisors, LLC holds $125,986,971 across 13 Drug Manufacturers - General names. ABBV ranks #6 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
157,263 | $38,441,367 | |
| 2 | MRK |
Merck & Co., Inc.
|
137,497 | $16,539,514 | |
| 3 | LLY |
ELI LILLY & Co
|
17,474 | $16,072,060 | |
| 4 | NVO |
Novo Nordisk A S
|
385,620 | $14,171,535 | |
| 5 | PFE |
Pfizer Inc
|
500,221 | $14,046,205 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
52,656 | $11,452,153 | |
| 7 | AMGN |
Amgen Inc
|
20,942 | $7,368,442 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
39,903 | $2,420,116 |
All Filings in ABBV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,452,153 | 52,656 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $11,278,037 | 49,359 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $11,030,102 | 47,638 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $12,788,104 | 68,894 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $18,092,471 | 86,352 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $23,264,128 | 130,918 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $25,237,549 | 127,798 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $22,074,795 | 128,701 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $23,597,246 | 129,584 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $22,909,680 | 147,833 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $28,748,307 | 192,864 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $26,577,243 | 197,263 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $33,274,384 | 208,787 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $32,846,586 | 203,246 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $30,111,624 | 224,362 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $34,088,974 | 222,571 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $38,250,827 | 235,956 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $32,756,238 | 241,922 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $27,783,212 | 257,562 | Shares | Sole | 2021-11-01 | |
| No filing history on record for this holder in this stock. | ||||||